Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keyur Patel

Showing results (211-220 of 357) with videos related to

Pageof 36
Sort By:
Journal of Hepatology|June 28, 2011
Beneficial IL28B genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis CHans L Tillmann, Keyur Patel, Andrew J Muir, et al.
Hepatology (Baltimore, Md.)|March 15, 2024
Noninvasive liver disease assessment to identify portal hypertension: Systematic and narrative reviews supporting the AASLD Practice GuidelineDon C Rockey, Mouaz Alsawas, Andres Duarte-Rojo, et al.
Hepatology (Baltimore, Md.)|September 10, 2014
Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1-infected patientsEric G Meissner, Yu-Jin Lee, Anu Osinusi, et al.
Blood|May 29, 2016
Impact of complete molecular response on survival in patients with Philadelphia chromosome-positive acute lymphoblastic leukemiaNicholas J Short, Elias Jabbour, Koji Sasaki, et al.
JHEP Reports : Innovation in Hepatology|September 24, 2021
Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis BLaurens A van Kleef, Hannah S J Choi, Willem P Brouwer, et al.
Hepatology (Baltimore, Md.)|February 10, 2012
Hepatitis C virus selectively perturbs the distal cholesterol synthesis pathway in a genotype-specific mannerPaul J Clark, Alexander J Thompson, David M Vock, et al.
Leukemia & Lymphoma|September 6, 2013
Mutated NPM1 in patients with acute myeloid leukemia in remission and relapsePreetesh Jain, Hagop Kantarjian, Keyur Patel, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 7, 2011
Steatosis is an independent predictor of relapse following rapid virologic response in patients with HCV genotype 3Samir R Shah, Keyur Patel, Patrick Marcellin, et al.
Journal of Hepatology|September 6, 2015
Dysregulation of distal cholesterol biosynthesis in association with relapse and advanced disease in CHC genotype 2 and 3 treated with sofosbuvir and ribavirinZobair M Younossi, Maria Stepanova, Michael Estep, et al.
Hepatology (Baltimore, Md.)|March 18, 2010
Interferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infectionJosephine H Li, Xiang Qian Lao, Hans L Tillmann, et al.
Pageof 36

Showing results (211-220 of 357) with videos related to

Sort By:
Pageof 36
Journal of Hepatology|June 28, 2011
Beneficial IL28B genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis CHans L Tillmann, Keyur Patel, Andrew J Muir, et al.
Hepatology (Baltimore, Md.)|March 15, 2024
Noninvasive liver disease assessment to identify portal hypertension: Systematic and narrative reviews supporting the AASLD Practice GuidelineDon C Rockey, Mouaz Alsawas, Andres Duarte-Rojo, et al.
Hepatology (Baltimore, Md.)|September 10, 2014
Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1-infected patientsEric G Meissner, Yu-Jin Lee, Anu Osinusi, et al.
Blood|May 29, 2016
Impact of complete molecular response on survival in patients with Philadelphia chromosome-positive acute lymphoblastic leukemiaNicholas J Short, Elias Jabbour, Koji Sasaki, et al.
JHEP Reports : Innovation in Hepatology|September 24, 2021
Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis BLaurens A van Kleef, Hannah S J Choi, Willem P Brouwer, et al.
Hepatology (Baltimore, Md.)|February 10, 2012
Hepatitis C virus selectively perturbs the distal cholesterol synthesis pathway in a genotype-specific mannerPaul J Clark, Alexander J Thompson, David M Vock, et al.
Leukemia & Lymphoma|September 6, 2013
Mutated NPM1 in patients with acute myeloid leukemia in remission and relapsePreetesh Jain, Hagop Kantarjian, Keyur Patel, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 7, 2011
Steatosis is an independent predictor of relapse following rapid virologic response in patients with HCV genotype 3Samir R Shah, Keyur Patel, Patrick Marcellin, et al.
Journal of Hepatology|September 6, 2015
Dysregulation of distal cholesterol biosynthesis in association with relapse and advanced disease in CHC genotype 2 and 3 treated with sofosbuvir and ribavirinZobair M Younossi, Maria Stepanova, Michael Estep, et al.
Hepatology (Baltimore, Md.)|March 18, 2010
Interferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infectionJosephine H Li, Xiang Qian Lao, Hans L Tillmann, et al.
Pageof 36